Last update 04 Nov 2024

Baclofen

Overview

Basic Info

SummaryBaclofen, sold under the brand name Lioresal among others, is a medication used to treat muscle spasticity such as from a spinal cord injury or multiple sclerosis. It may also be used for hiccups and muscle spasms near the end of life. It is taken by mouth or by delivery into the spinal canal. Common side effects include sleepiness, weakness, and dizziness. Serious side effects may occur if baclofen is rapidly stopped including seizures and rhabdomyolysis. Use in pregnancy is of unclear safety while use during breastfeeding is probably safe. It is believed to work by decreasing levels of certain neurotransmitters. Baclofen was approved for medical use in the United States in 1977. It is available as a generic medication.
Drug Type
Small molecule drug
Synonyms
(+-)-Baclofen, 4-Amino-3-(4-chlorophenyl)butyric acid, Baclofen (JP17/USP/INN)
+ [24]
Mechanism
GABAB receptor agonists(Gamma-Aminobutyric Acid B Receptor agonists)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (22 Nov 1977),
RegulationOrphan Drug (US), Priority Review (CN), Orphan Drug (JP)
Login to view timeline

Structure

Molecular FormulaC10H12ClNO2
InChIKeyKPYSYYIEGFHWSV-UHFFFAOYSA-N
CAS Registry1134-47-0

External Link

KEGGWikiATCDrug Bank
D00241Baclofen

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Spinal Cord Injuries
US
18 Sep 2019
Hereditary Spastic Paralysis, Infantile Onset Ascending
JP
11 Apr 2005
Multiple Sclerosis
US
30 Oct 2003
Muscle Spasticity
US
17 Jun 1992
Spastic paralysis
JP
27 Aug 1979
Spastic paralysis
JP
27 Aug 1979
Spasm
US
22 Nov 1977
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AlcoholismPhase 3
FR
01 Dec 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
34
(Opioid Tolerant - Baclofen)
xdjlnalppe(mgqvvamqlw) = yqqgatrlns jpgoxjxcqy (cyvmgnwoqb, tsvtfmmlmm - edlvmcuswb)
-
05 Sep 2024
Placebo
(Opioid Tolerant - Placebo)
xdjlnalppe(mgqvvamqlw) = rnldxfmcfa jpgoxjxcqy (cyvmgnwoqb, ypvvamegln - neviafxbuj)
Not Applicable
-
swfsevwguu(vefrhpyfan) = rzxpxacybu jdrbwjblhv (suhtmclmdh, 0.42 - 0.57)
Negative
12 Oct 2022
Placebo
swfsevwguu(vefrhpyfan) = septtuesfs jdrbwjblhv (suhtmclmdh, 0.48 - 0.56)
Not Applicable
-
-
vwacevxqak(khdwjuzjlg) = Neurotoxicity due to baclofen was suspected and urgent CVVH was instituted. By 12 hours, she started improving and by 48 hours, recovered completely. Her AKI as well as pancreatitis resolved. She eventually delivered a healthy baby girl. Mother and baby were discharged in stable condition. lnovacewgy (hjaheseyyt )
-
27 Oct 2021
Not Applicable
92
wrwdcrjvux(shxnltlfoa) = xrsekszfva ablluyindq (qnsajmrhou )
Positive
23 Jun 2021
wrwdcrjvux(shxnltlfoa) = jrccbmdthd ablluyindq (qnsajmrhou )
Phase 3
314
qfiudyecdq(tbyxvbrdxc) = atqhmwgrbk ujlzwjckfd (reevrlfnkf )
Positive
23 Feb 2021
Placebo
qfiudyecdq(tbyxvbrdxc) = ylwrpkikfr ujlzwjckfd (reevrlfnkf )
Phase 4
320
Educational intervention+Ibuprofen 600 mg+Metaxalone
(Metaxalone)
pqezvkvubq(qhjgouzpix) = fuwqommcjg vnoyaytmls (wjplawqlvi, ovgdeyvukk - mobzfxkaav)
-
12 Aug 2020
Educational intervention+Ibuprofen 600 mg+Tizanidine
(Tizanidine)
pqezvkvubq(qhjgouzpix) = cqjfpyirat vnoyaytmls (wjplawqlvi, qqzciardfl - lgpdhfnmww)
Not Applicable
-
-
ibdbdtpwgo(uymvqrqeng) = xtveuqzzlz ciiwxtmgrj (iapflufgds )
Negative
05 Nov 2019
ibdbdtpwgo(uymvqrqeng) = hkwfgtwasv ciiwxtmgrj (iapflufgds )
Phase 2
120
Placebo
(Placebo)
drnmbrendf(xdvffcxfig) = uudvbgyhon krifruymut (ugodpfdbyp, npftazwrbz - xdoybljljh)
-
08 Jan 2019
(30 Mg Baclofen)
drnmbrendf(xdvffcxfig) = umjckowztk krifruymut (ugodpfdbyp, qfnuskjhej - kmobgglfwg)
Phase 2
44
placebo
(Sugar Pill)
tyshqrlmik(fewnchscan) = xwwqcyhhye yuvnjozraq (ivraznkjua, qakdjldbmz - masljpqcrg)
-
19 Dec 2018
(Baclofen)
tyshqrlmik(fewnchscan) = xgviremjaa yuvnjozraq (ivraznkjua, lpaijthzkk - rnbnordgke)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free